Cargando…

Anti-Helicobacter pylori Properties of GutGard™

Presence of Helicobacter pylori is associated with an increased risk of developing upper gastrointestinal tract diseases. Antibiotic therapy and a combination of two or three drugs have been widely used to eradicate H. pylori infections. Due to antibiotic resistant drugs, new drug resources are need...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae Min, Zheng, Hong Mei, Lee, Boo Yong, Lee, Woon Kyu, Lee, Don Haeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Food Science and Nutrition 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892500/ https://www.ncbi.nlm.nih.gov/pubmed/24471118 http://dx.doi.org/10.3746/pnf.2013.18.2.104

Ejemplares similares

Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study
por: Puram, Sreenivasulu, et al.
Publicado: (2013)

Acute and Subchronic Toxicity Study of Flavonoid Rich Extract of Glycyrrhiza glabra (GutGard®) in Sprague Dawley Rats
por: Bhide, Ranjit M., et al.
Publicado: (2022)

An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study
por: Raveendra, Kadur Ramamurthy, et al.
Publicado: (2012)

In vitro and In vivo Anti-Helicobacter pylori Activities of Centella asiatica Leaf Extract
por: Zheng, Hong-Mei, et al.
Publicado: (2016)

Dietary prevention of Helicobacter pylori-associated gastric cancer with kimchi
por: Jeong, Migyeong, et al.
Publicado: (2015)

Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection
por: Kwon, Tae Jin, et al.
Publicado: (2021)

Science Avant-Garde
por: Potter, Polyxeni
Publicado: (2012)

Dr. Gard Foster
Publicado: (1915)

Structural Analysis of Glutamine Synthetase from Helicobacter pylori
por: Joo, Hyun Kyu, et al.
Publicado: (2018)

Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection
por: Kim, Se-eun, et al.
Publicado: (2020)

Aspirin Use Is Not Associated with the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection
por: Kim, Ji Eun, et al.
Publicado: (2021)

Anti-Helicobacter pylori Properties of the Ant-Venom Peptide Bicarinalin
por: Guzman, Jesus, et al.
Publicado: (2017)

Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease
por: Kim, Tae Jun, et al.
Publicado: (2016)

Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation
por: Yang, Ji Yeong, et al.
Publicado: (2021)

Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients
por: Park, Dong-Wook, et al.
Publicado: (2010)

Plant-Based Polyphenols: Anti-Helicobacter pylori Effect and Improvement of Gut Microbiota
por: Guerra-Valle, María, et al.
Publicado: (2022)

Helicobacter pylori: Perturbation and restoration of gut microbiome
por: Saxena, Ankita, et al.
Publicado: (2020)

Impact of Helicobacter pylori infection on gut microbiota
por: Iino, Chikara, et al.
Publicado: (2021)

Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
por: Yoon, Kyu-Hyun, et al.
Publicado: (2014)

A dictionary of the avant-gardes /
por: Kostelanetz, Richard
Publicado: (2000)

Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)

Lack of Association between Past Helicobacter pylori Infection and Diabetes: A Two-Cohort Study
por: Pyo, Jeung Hui, et al.
Publicado: (2019)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Anti-Helicobacter pylori activity of ethoxzolamide
por: Modak, Joyanta K., et al.
Publicado: (2019)

Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults
por: Yap, Theresa Wan-Chen, et al.
Publicado: (2016)

Helicobacter pylori Associated Lymphocytic Gastritis in a Child
por: Kim, Min Jeong, et al.
Publicado: (2014)

Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis
por: Shen, Huili, et al.
Publicado: (2022)

The complete methylome of Helicobacter pylori UM032
por: Lee, Woon Ching, et al.
Publicado: (2015)

Helicobacter pylori in Dental Plaque and Saliva
por: Kim, Nayoung, et al.
Publicado: (2000)

Helicobacter pylori: a poor man's gut pathogen?
por: Khalifa, Mohammed Mahdy, et al.
Publicado: (2010)

Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota
por: Yang, Yao-Jong, et al.
Publicado: (2016)

Exploring the impact of Helicobacter pylori on gut microbiome composition
por: Dash, Nihar Ranjan, et al.
Publicado: (2019)

The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota
por: Fiorani, Marcello, et al.
Publicado: (2023)

Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Anti-Helicobacter pylori activity and inhibition of gastritis by Allium hookeri extract
por: Lee, Hyun-A, et al.
Publicado: (2018)

Functional and Molecular Surveillance of Helicobacter pylori Antibiotic Resistance in Kuala Lumpur
por: Teh, Xinsheng, et al.
Publicado: (2014)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations
por: Yu, Jin-Han, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ramjvait4p2lrsk78iucgrt5st